gms | German Medical Science

69. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Mexikanischen und Kolumbianischen Gesellschaft für Neurochirurgie

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

03.06. - 06.06.2018, Münster

Neuro-Oncology: Clinical

Meeting Abstract (P052)

TTFields for newly diagnosed glioblastoma: Impact of consultation strategy

Haj A, Proescholdt M, Doenitz C, Hohenberger C, Brawanski A
[Full Text]
Meeting Abstract (P053)

Unusual malignant course of a pilocytic astrocytoma: relevance of the assessment of H3F3A K27M mutation in adult patients

Kellermann S, Hamisch C, Grau S, Goldbrunner R, Hampl J
[Full Text]
Meeting Abstract (P054)

Deep seated not accessible glioblastoma multiforme – analysis of patients’ overall survival after stereotactic biopsy and adjuvant treatment

Brüning AR, Lehmann A, Rathert J, Gerlach R
[Full Text]
Meeting Abstract (P055)

Influence of clinical and molecular markers on survival of primary glioblastoma

Ahmadipour Y, Gembruch O, Pierscianek D, Zkan N, Müller O, Sure U, El Hindy N
[Full Text]
Meeting Abstract (P056)

5-ALA – photodynamic therapy in recurrent malignant glioma – a retrospective data analysis

Schroeteler J, Hetkamp T, Schwake M, Ewelt C, Stummer W
[Full Text]
Meeting Abstract (P057)

Clinicoradiographic key features of biopsy-proven treatment-induced necrosis in patients with malignant glioma

Winter SF, Löbel F, Vaios EJ, Bertalan MS, Bussière M, Shih HA, Muzikansky A, Martinez-Lage M, Vajkoczy P, Dietrich J
[Full Text]
Meeting Abstract (P058)

Impact of carmustine implantation in first recurrence of glioblastoma patients – a retrospective monocentric analysis

Köber S, Kremer B, Kamp MA, Steiger HJ, Sabel M, Rapp M
[Full Text]
Meeting Abstract (P059)

Surgical and oncological management of WHO grade III gliomas in the era of molecular-genetic markers

Delev D, Heiland DH, Haaker G, Franco P, Schnell O
[Full Text]
Meeting Abstract (P060)

Persisting FLAIR-hyperintensity at follow-up after resection of glioblastoma correlates with localization of recurrence

Bettag C, Sachkova A, Psychogios M, Schregel K, Rohde V, Malinova V
[Full Text]
Meeting Abstract (P061)

Investigation of the interaction of simultaneously applied irradiation and tumor treating fields (TTFields) using a Geant4 simulation

Mayer M, Hürtgen G, Schlenter M, Eble MJ, Stahl A
[Full Text]
Meeting Abstract (P062)

The impact of carmustine implantation A retrospective monocentric analysis for recurrent high grade glioma patients

Köber S, Kamp MA, Steiger HJ, Sabel M, Rapp M
[Full Text]
Meeting Abstract (P063)

The role of surgery in the treatment of recurrent glioblastoma

Pala A, Schmitz L, Knoll A, Hlavac M, König R, Wirtz CR, Coburger J
[Full Text]
Meeting Abstract (P064)

Implantation of carmustine wafers after resection of malignant glioma with and without opening of the ventricular system

Hussein A, Abboud T, Mielke D, Rohde V
[Full Text]
Meeting Abstract (P065)

Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumor-treating fields: Initial experiences

Ceccon G, Lazaridis L, Stoffels G, Rapp M, Lohmann P, Kebir S, Fink GR, Langen KJ, Glas M, Galldiks N
[Full Text]
Meeting Abstract (P066)

Glioblastomatherapy withTTFields: Theroleofnurses in clinical routine

Kilias M, Pellet C, Hottinger A
[Full Text]
Meeting Abstract (P067)

Multiple effects of temozolomide treatment on glioblastoma cells

Barciszewska AM, Belter A
[Full Text]